margaret2020-11-24T20:53:23-05:00Bridge Medicines Adds Small Molecule Inhibitors of Activated Factor XII to Pipelinemargaret2020-11-24T20:53:23-05:00September 21, 2020|
margaret2020-11-24T21:12:14-05:00Bridge Medicines Enters Exclusive License Agreement with The Rockefeller University for Novel Epigenetic Leukemia Programmargaret2020-11-24T21:12:14-05:00March 16, 2020|
Bridge Medicines Appoints William J. Polvino, M.D., As Chief Executive Officer Gallery Bridge Medicines Appoints William J. Polvino, M.D., As Chief Executive Officer Press Releases Bridge Medicines Appoints William J. Polvino, M.D., As Chief Executive Officermargaret2020-11-24T20:52:32-05:00March 27, 2017|
Pioneering Drug Discovery Company Bridge Medicines Launched to Advance Promising Early Technologies in Major Academic Institutions through Human Proof of Concept Gallery Pioneering Drug Discovery Company Bridge Medicines Launched to Advance Promising Early Technologies in Major Academic Institutions through Human Proof of Concept Press Releases Pioneering Drug Discovery Company Bridge Medicines Launched to Advance Promising Early Technologies in Major Academic Institutions through Human Proof of Conceptmargaret2020-11-24T20:51:48-05:00October 31, 2016|